Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-VEGFA Antibody (9C236)

😃Good
Catalog No. TMAY-00344
Alias VPF, VEGF-A, VEGF, MVCD1, L-VEGF

Anti-VEGFA Antibody (9C236) is a Mouse antibody targeting VEGFA. Anti-VEGFA Antibody (9C236) can be used in IHC-P.

Anti-VEGFA Antibody (9C236)

Anti-VEGFA Antibody (9C236)

😃Good
Catalog No. TMAY-00344Alias VPF, VEGF-A, VEGF, MVCD1, L-VEGF
Anti-VEGFA Antibody (9C236) is a Mouse antibody targeting VEGFA. Anti-VEGFA Antibody (9C236) can be used in IHC-P.
Pack SizePriceAvailabilityQuantity
100 μL$199 7-10 days
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Anti-VEGFA Antibody (9C236) is a Mouse antibody targeting VEGFA. Anti-VEGFA Antibody (9C236) can be used in IHC-P.
AliasVPF, VEGF-A, VEGF, MVCD1, L-VEGF
Ig Type
Monoclonal Mouse IgG3
Clone
9C236
Reactivity
Human
Verified Activity
1. Immunochemical staining of human VEGFA in human liver with mouse monoclonal antibody(1:30, formalin-fixed paraffin embedded sections).

2. Immunochemical staining of human VEGFA in human hepatoma with mouse monoclonal antibody(1:30, formalin-fixed paraffin embedded sections).
Application
IHC-P
Recommended Dose
IHC-P: 1:20-1:100
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with a synthetic peptide corresponding to the C-terminus of the Human VEGF/VEGFA. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundVascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
A synthetic peptide corresponding to the C-terminus of the Human VEGF/VEGFA
Antigen Species
Human
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-VEGFA Antibody (9C236) | purchase Anti-VEGFA Antibody (9C236) | Anti-VEGFA Antibody (9C236) cost | order Anti-VEGFA Antibody (9C236)